Satellos Bioscience Inc. Announces the Filing of Final Short Form Prospectus for Proposed Offering of Units
Toronto, Ontario--(Newsfile Corp. - September 7, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change